| |
| Frequently Asked Questions |
 |
|
- Investor Stock Information
When was the Company founded and when did it go public? |
|
| |
Gen-Probe was founded in 1983 and went public in 1987. It was acquired by Chugai Pharmaceutical Co., Ltd in 1989 and spun-off from Chugai Pharmaceutical as a result of Chugai's merger with Nippon Roche on September 15, 2002. Gen-Probe began trading on the Nasdaq on September 16, 2002. |
|
|
|
Where does Gen-Probe's stock trade and what is its ticker symbol? |
|
| |
Gen-Probe is listed on the Nasdaq Global Select Market under ticker symbol "GPRO." |
|
|
|
When did Gen-Probe begin trading on the NASDAQ stock exchange? |
|
| |
September 16, 2002. |
|
|
|
What is Gen-Probe's CUSIP number? |
|
| |
36866T103 |
|
|
|
Do you have a DRIP (Dividend Reinvestment Plan)? |
|
| |
Gen-Probe does not pay a dividend and therefore does not have a DRIP. |
|
|
|
Do you anticipate paying a dividend? |
|
| |
Gen-Probe does not anticipate paying any dividends on its Common Stock in the foreseeable future because the Company expects to retain its future earnings for use in the operation and expansion of its business. |
|
|
|
Who should I contact to change the address on my stock certificates or on my DRS statement (a full book-entry ownership)? |
|
| |
Change of address requests should be taken care of through Gen-Probe's transfer agent, Mellon Investor Services:
Mellon Investor Services, LLC
85 Challenger Road
Ridgefield Park, NJ 07666
(800) 903-1224 Domestic
(201) 329-8728 International
www.melloninvestor.com
Japanese Language:
(201) 329-8453
Toll-Free from Japan: 00531-11-4916 |
|
|
|
Who can help me with transferring my certificates into a trust or another name? |
|
| |
To transfer your certificate into another name, please contact Mellon Investor Services
Mellon Investor Services, LLC
85 Challenger Road
Ridgefield Park, NJ 07666
(800) 903-1224 Domestic
(201) 329-8728 International
www.melloninvestor.com
Japanese Language:
(201) 329-8453
Toll-Free from Japan: 00531-11-4916 |
|
|
|
How many shares are outstanding? |
|
| |
As of June 30, 2005, 50,665,626 shares were outstanding. |
|
|
|
Who can I contact if I have more questions or need more information? |
|
| |
Please email your request to IR@gen-probe.com or call Michael Watts, Vice President, Investor Relations and Corporate Communications
at 858-410-8673. |
|
|
|
How do I obtain an investor kit? |
|
|
|
How can I get a copy of the current Annual Report? |
|
| |
Copies of Gen-Probe's current Annual Report or Form 10-K can be obtain by request from the Company by sending an email to IR@gen-probe.com or through the Company's IR section under "SEC Filings." |
|
|
|
When was the Company incorporated and in what state? |
|
| |
Gen-Probe was incorporated in California in 1984 and reincorporated in Delaware in 1987. |
|
|
|
What is the Company's fiscal year? |
|
| |
Gen-Probe's fiscal year is on a calendar basis, from January 1st to December 31st. |
|
|
|
Who are the members of Gen-Probe's Board of Directors? |
|
| |
Henry L. Nordhoff - Chairman, Gen-Probe Inc.
John W. Brown - Chairman, Stryker Corporation
Raymond V. Dittamore - Former Partner, Ernst & Young
Carl W. Hull, President and Chief Executive Officer, Gen-Probe Inc.
Armin M. Kessler - Former Chief Operating Officer, Hoffman-La Roche
John C. Martin, Ph.D., Chairman and Chief Operating Officer, Hoffman-La Roche
Phillip M. Schneider - Former Chief Financial Officer, IDEC Pharmaceuticals
Lucy Shapiro, Ph.D. - Virginia and D.K. Ludwig Professor
The Honorable Abraham D. Sofaer - George P. Schultz Distinguished Scholar and Senior Fellow, The Hoover Institution, Stanford University |
|
|
|
How many employees does Gen-Probe have? |
|
| |
The Company has approximately 800 employees. |
|
|
|
Describe the Gen-Probe facilities? |
|
| |
Gen-Probe's worldwide headquarters are located in a 262,000 square-foot facility in San Diego, California. Gen-Probe owns this facility and an adjacent 23-acre parcel, which is currently under construction for a new 290,000 sq ft facility due to be completed in 2006. Gen-Probe also leases a separate 93,500 square foot manufacturing facility located in Rancho Bernardo, California. |
|
|
|
How can I reach Gen-Probe's Investor Relations? |
|
| |
Email requests can be sent to IR@gen-probe.com. Additionally, please contact Michael Watts, Senior Director of Investor Relations and Corporate Communications at telephone: 858-410-8673 or fax: 858-410-9122.
|
|
|
|
Who is Gen-Probe's Transfer Agent, how can I contact them? |
|
| |
Mellon Investor Services, LLC
85 Challenger Road
Ridgefield Park, NJ 07666
(800) 903-1224 Domestic
(201) 329-8728 International
www.melloninvestor.com
Japanese Language:
(201) 329-8453
Toll-Free from Japan: 00531-11-4916 |
|
|
|
How do I find out about job opportunities at Gen-Probe? |
|
| |
A complete list of job postings is available from the homepage on Gen-Probe's website. |
|
|
|
|
